The Life Sciences Practice at Mintz – recognized by Chambers USA, Chambers Canada, and Chambers Global – will be showcasing its commitment to the industry ecosystem in a variety of different ways during the upcoming BIO 2025 International Convention.

Corporate & Securities Member Matthew Gardella was selected to moderate a panel discussion at the upcoming 2025 BIO International Convention in Boston. Matt’s June 19th panel session entitled “Biotech M&A 2025: What’s Driving Deal-Making in The New Environment,” examines the shifting landscape of biotech M&A, exploring how market volatility, limited IPO opportunities, and increased shareholder activism are influencing deal-making in 2025.

Panelists include William Fiske, Head of M&A and Contested Situations, Georgeson LLC; Dan P. Moore, Founding Partner, Collected Strategies; Janet Raimondo, JD, Global Head Legal Transactions, Novartis; and Frank Fekete , Managing Director,, Centerview Partners LLC.

On June 16, Intellectual Property Partner Anthony de Fazekas will be moderating a panel session at a special event hosted by Clinical Trials Ontario, Life Sciences Ontario, and OBIO titled “The AI Opportunity: Revolutionizing Clinical Trials, Transforming Healthcare.” Designed for leaders in the pharmaceutical and medical device industries, CROs, and business and healthcare innovators, this event will highlight the strength of Canada’s research ecosystem and its role in advancing the future of global healthcare. The panel will examine how artificial intelligence is reshaping clinical trials and the broader healthcare landscape.

Speakers at the event include Adam Marsella, VP, Patient Access & Public Affairs, Novo Nordisk; Dr. Bettina Hamelin, President of Innovative Medicines Canada; Brigitte Nolet, President & CEO at Roche Canada Pharmaceuticals; Dr. Christine Allen PhD, CEO of Intrepid Labs, Co-Director, Acceleration Consortium at UofT; Dr. Fahad Razak MD, Provincial Clinical Lead, Ontario Health, Co-Lead GEMINI, Canada Research Chair in Data-Informed Healthcare Improvement at UofT; Lucas Siow, Co-founder & CEO at ProteinQure; and Sebastien Latapie, Partner, Avant BIO.

Mintz is hosting a networking reception with the Consulate General of Canada-Boston featuring leaders from Canada’s life sciences sector, political leadership, and Canadians working in Greater Boston’s biotech industry, featuring remarks by Cheryl Reicin, International Chair, Life Sciences.

Mintz is hosting the Licensing Executives Society of the USA & Canada (LES) Royalty Rate Survey launch. Invitees are senior business development leaders of the world’s leading biopharmaceutical companies. This event will feature remarks from Corporate & Securities attorney Adam Falconi, LES’ Life Science Sector Chair.

Additionally, the firm will host its Annual BIO Networking Reception for C-Suite clients, prospects, and investors on June 16.

The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.

More information about the 2025 BIO International Convention can be found here.

As a law firm steeped in the life sciences, Mintz provides legal and business counsel to life sciences companies, investors, and leaders worldwide. Learn more by visiting www.mintz.com.